257 related articles for article (PubMed ID: 18458871)
1. Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.
Skovbro M; Baranowski M; Skov-Jensen C; Flint A; Dela F; Gorski J; Helge JW
Diabetologia; 2008 Jul; 51(7):1253-60. PubMed ID: 18458871
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?
Amati F; Dubé JJ; Alvarez-Carnero E; Edreira MM; Chomentowski P; Coen PM; Switzer GE; Bickel PE; Stefanovic-Racic M; Toledo FG; Goodpaster BH
Diabetes; 2011 Oct; 60(10):2588-97. PubMed ID: 21873552
[TBL] [Abstract][Full Text] [Related]
3. Training Does Not Alter Muscle Ceramide and Diacylglycerol in Offsprings of Type 2 Diabetic Patients Despite Improved Insulin Sensitivity.
Søgaard D; Østergård T; Blachnio-Zabielska AU; Baranowski M; Vigelsø AH; Andersen JL; Dela F; Helge JW
J Diabetes Res; 2016; 2016():2372741. PubMed ID: 27777958
[TBL] [Abstract][Full Text] [Related]
4. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
5. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide.
Dubé JJ; Amati F; Toledo FG; Stefanovic-Racic M; Rossi A; Coen P; Goodpaster BH
Diabetologia; 2011 May; 54(5):1147-56. PubMed ID: 21327867
[TBL] [Abstract][Full Text] [Related]
6. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
7. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.
Straczkowski M; Kowalska I; Baranowski M; Nikolajuk A; Otziomek E; Zabielski P; Adamska A; Blachnio A; Gorski J; Gorska M
Diabetologia; 2007 Nov; 50(11):2366-73. PubMed ID: 17724577
[TBL] [Abstract][Full Text] [Related]
8. Muscle-Saturated Bioactive Lipids Are Increased with Aging and Influenced by High-Intensity Interval Training.
Søgaard D; Baranowski M; Larsen S; Taulo Lund M; Munk Scheuer C; Vestergaard Abildskov C; Greve Dideriksen S; Dela F; Wulff Helge J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871020
[TBL] [Abstract][Full Text] [Related]
9. Increased skeletal muscle capillarization after aerobic exercise training and weight loss improves insulin sensitivity in adults with IGT.
Prior SJ; Blumenthal JB; Katzel LI; Goldberg AP; Ryan AS
Diabetes Care; 2014 May; 37(5):1469-75. PubMed ID: 24595633
[TBL] [Abstract][Full Text] [Related]
10. Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose.
Goossens GH; Moors CC; Jocken JW; van der Zijl NJ; Jans A; Konings E; Diamant M; Blaak EE
Nutrients; 2016 Mar; 8(3):164. PubMed ID: 26985905
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 × 2 factorial, randomised, crossover study in human individuals.
Hjelholt AJ; Charidemou E; Griffin JL; Pedersen SB; Gudiksen A; Pilegaard H; Jessen N; Møller N; Jørgensen JOL
Diabetologia; 2020 Dec; 63(12):2641-2653. PubMed ID: 32945898
[TBL] [Abstract][Full Text] [Related]
12. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus.
Kristensen D; Prats C; Larsen S; Ara I; Dela F; Helge JW
Acta Diabetol; 2013 Oct; 50(5):705-12. PubMed ID: 22350135
[TBL] [Abstract][Full Text] [Related]
13. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.
Perreault L; Newsom SA; Strauss A; Kerege A; Kahn DE; Harrison KA; Snell-Bergeon JK; Nemkov T; D'Alessandro A; Jackman MR; MacLean PS; Bergman BC
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415895
[TBL] [Abstract][Full Text] [Related]
14. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle.
Straczkowski M; Kowalska I; Nikolajuk A; Dzienis-Straczkowska S; Kinalska I; Baranowski M; Zendzian-Piotrowska M; Brzezinska Z; Gorski J
Diabetes; 2004 May; 53(5):1215-21. PubMed ID: 15111489
[TBL] [Abstract][Full Text] [Related]
15. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
16. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
17. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
[TBL] [Abstract][Full Text] [Related]
18. Effect of gender on lipid-induced insulin resistance in obese subjects.
Vistisen B; Hellgren LI; Vadset T; Scheede-Bergdahl C; Helge JW; Dela F; Stallknecht B
Eur J Endocrinol; 2008 Jan; 158(1):61-8. PubMed ID: 18166818
[TBL] [Abstract][Full Text] [Related]
19. Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes.
Petersen KF; Dufour S; Morino K; Yoo PS; Cline GW; Shulman GI
Proc Natl Acad Sci U S A; 2012 May; 109(21):8236-40. PubMed ID: 22547801
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats.
Takagi H; Ikehara T; Hashimoto K; Tanimoto K; Shimazaki A; Kashiwagi Y; Sakamoto S; Yukioka H
Eur J Pharmacol; 2021 Nov; 910():174451. PubMed ID: 34454928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
